Lifestyle intervention and treatment with metformin provide safe, long-term, cost-effective means of preventing Type 2 diabetes and should be incorporated into prevention strategies for reducing the dramatic rise in incidence of Type 2 diabetes in the United States, according to two new analyses and an editorial published in the April issue of Diabetes Care.
The Consumer Healthcare Products Association and the other members of the Health Choices Coalition on Friday sent letters to members of Congress urging the repeal of the requirement that prevents consumers from using their flexible spending arrangements to purchase over-the-counter medicines without first getting a doctor’s prescription.
Lawmakers are going after companies that they say have sought to take advantage of drug shortages by buying drugs in short supply and then reselling them at higher prices, according to published reports.
NACDS RxImpact Day on Capitol Hill showcased the unsurpassed value of community pharmacy as pharmacy advocates from 41 states conducted more than 350 meetings with U.S. senators and representatives this week.
GlaxoSmithKline on Thursday morning presented exactly how technology might improve appropriate patient self-selection before a panel convened by the Food and Drug Administration to explore expanding the prescripton-to-over-the-counter switch paradigm by incorporating technology and/or pharmacy participation in the application process.